Abstract
Objective: To investigate whether transdermal low dose estradiol treatment induces changes in mammographic density or heterogeneity compared to raloxifene. Secondarily, if these changes relate to changes in bone formation/resorption markers, and if these findings indicate elevation of breast cancer risk by treatment.
Original language | English |
---|---|
Journal | Menopause |
Volume | 16 |
Issue number | 4 |
Pages (from-to) | 785-791 |
Number of pages | 7 |
ISSN | 1072-3714 |
DOIs | |
Publication status | Published - 2009 |